Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 448

Results For "IND"

6581 News Found

Lonza introduces X-ray powder diffraction at Monteggio
News | August 23, 2022

Lonza introduces X-ray powder diffraction at Monteggio

This rapid analytical technique provides additional information about the polymorph and solid-state properties of active pharmaceutical ingredients (APIs)


Dr. Jitendra Singh announces 75 Amrit Grants for biotech initiatives
Policy | August 23, 2022

Dr. Jitendra Singh announces 75 Amrit Grants for biotech initiatives

75 inter-disciplinary, multi-institutional grants would be supported for high-risk, ambitious research ideas, milestones-driven collaborative research in all domain areas of the biotech sector


PM to inaugurate Amrita Hospital and Homi Bhabha Cancer Hospital & Research Centre
Policy | August 23, 2022

PM to inaugurate Amrita Hospital and Homi Bhabha Cancer Hospital & Research Centre

The hospital is being constructed at an estimated cost of around Rs. 6,000 crore and will provide healthcare facilities to the people of Faridabad and the entire NCR region


DCGI approves AstraZeneca 's Olaparib film-coated tablets
Drug Approval | August 20, 2022

DCGI approves AstraZeneca 's Olaparib film-coated tablets

Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer


Shilpa Medicare completes clinical studies of high concentration biosimilar Adalimumab
Clinical Trials | August 20, 2022

Shilpa Medicare completes clinical studies of high concentration biosimilar Adalimumab

The drug is expected to cater to the fast growing Rheumatoid Arthritis, Plaque Psoriasis, JIA, Psoriatic Arthritis, Ankylosing Spondylitis, Ulcerative Colitis, Crohns disease, HS and Uveitis markets


Godrej reveals how to win the war against Malaria through strategic collaboration
Public Health | August 20, 2022

Godrej reveals how to win the war against Malaria through strategic collaboration

~96% decline reported in Malaria cases in Madhya Pradesh, due to public-private-people partnership


Swissmedic approves Kapruvia with additional regulatory decisions expected in H2 2022
Drug Approval | August 20, 2022

Swissmedic approves Kapruvia with additional regulatory decisions expected in H2 2022

Therapy recently approved in Canada under the brand name KORSUVA


Lupin receives approval from U.S. FDA for Rufinamide Tablets USP
Drug Approval | August 19, 2022

Lupin receives approval from U.S. FDA for Rufinamide Tablets USP

The product will be manufactured at Lupin's facility in Goa, India.


WuXi STA breaks ground for second manufacturing facility in US
News | August 19, 2022

WuXi STA breaks ground for second manufacturing facility in US

This biopharmaceutical facility is one most significant private sector investment ever in the Middletown region


QPharma launches Ti OrderPoint 2
Digitisation | August 19, 2022

QPharma launches Ti OrderPoint 2

OrderPoint was designed as an advanced DTR solution from its first release in 2016.